Charles Explorer logo
🇬🇧

Komentář ke studii (Liraglutid vs. inhibitory SGLT-2 u pacientů s diabetes mellitus 2. typu - výsledky síťové metaanalýzy)

Publication at First Faculty of Medicine |
2016

This text is not available in the current language. Showing version "cs".Abstract

Komentář ke studii (Lorenzi M, Ploug U, Langer J, et al. Liraglutide vs SGLT-2 inhibitors in people with type 2 diabetes: a network meta-analysis. 2015 World diabetes Congress, abstract 0226-P).